These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7046362)

  • 1. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 2. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 4. SAMe (S-adenosylmethionine).
    Echols JC; Naidoo U; Salzman C
    Harv Rev Psychiatry; 2000; 8(2):84-90. PubMed ID: 10902097
    [No Abstract]   [Full Text] [Related]  

  • 5. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid antidepressant response with SAMe. A double-blind study.
    Potkin SG; Bell K; Plon L; Bunney WE
    Ala J Med Sci; 1988 Jul; 25(3):313-6. PubMed ID: 3052140
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP
    Psychopharmacol Bull; 1986; 22(1):186-91. PubMed ID: 3523576
    [No Abstract]   [Full Text] [Related]  

  • 8. S-adenosylmethionine in depression. A literature review and preliminary report.
    Janicak PG; Lipinski J; Davis JM; Comaty JE; Waternaux C; Cohen B; Altman E; Sharma RP
    Ala J Med Sci; 1988 Jul; 25(3):306-13. PubMed ID: 3052139
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring S-adenosyl-methionine blood levels and antidepressant effect.
    Del Vecchio M; Amati A; Vacca L; Zizolfi S
    Acta Neurol (Napoli); 1980 Dec; 2(6):488-95. PubMed ID: 7027755
    [No Abstract]   [Full Text] [Related]  

  • 10. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorder.
    Borison RL; Sinha D; Albrecht JW; Geber S; Diamond BI
    Psychopharmacol Bull; 1989; 25(2):186-9. PubMed ID: 2690163
    [No Abstract]   [Full Text] [Related]  

  • 13. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant response and plasma concentrations of bupropion.
    Preskorn SH
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):137-9. PubMed ID: 6406443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.
    Miccoli L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled clinical study of SAMe (S-adenosylmethionine) administered orally in degenerative osteoarticular pathology].
    Cucinotta D; Mancini M; Ceccato S; Castino E
    G Clin Med; 1980 Jul; 61(7):553-66. PubMed ID: 7004982
    [No Abstract]   [Full Text] [Related]  

  • 20. Early behavioural changes during antidepressant treatment in elderly patients.
    Kok RM; Vink D; Westers P; Nolen WA; Heeren TJ
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):769-71. PubMed ID: 18200609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.